- Home
- TITN vs AUTL Comparison
TITN vs AUTL Comparison
Compare TITN & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TITN | AUTL |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.9M | 368.6M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TITN | AUTL |
|---|---|---|
| Price | $16.28 | $1.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $21.50 | $8.33 |
| AVG Volume (30 Days) | 237.0K | ★ 3.9M |
| Earning Date | 11-25-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,545,195,000.00 | $51,128,000.00 |
| Revenue This Year | N/A | $658.11 |
| Revenue Next Year | N/A | $91.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $12.50 | $1.11 |
| 52 Week High | $23.41 | $2.80 |
Technical Indicators
Market Signals| Indicator | TITN | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 56.04 |
| Support Level | $15.97 | $1.46 |
| Resistance Level | $16.58 | $1.69 |
| Average True Range (ATR) | 0.65 | 0.10 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 19.49 | 70.67 |
Price Performance
Historical ComparisonAbout TITN Titan Machinery Inc.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.